Ε. Frederick Wheelock
About
In The Last Decade
Ε. Frederick Wheelock
76 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Immunology 1.2k
- Epidemiology 700
- Oncology 518
- Molecular Biology 434
- Infectious Diseases 357
Countries citing papers authored by Ε. Frederick Wheelock
This map shows the geographic impact of Ε. Frederick Wheelock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ε. Frederick Wheelock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ε. Frederick Wheelock more than expected).
Fields of papers citing papers by Ε. Frederick Wheelock
This network shows the impact of papers produced by Ε. Frederick Wheelock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ε. Frederick Wheelock. The network helps show where Ε. Frederick Wheelock may publish in the future.
Co-authorship network of co-authors of Ε. Frederick Wheelock
This figure shows the co-authorship network connecting the top 25 collaborators of Ε. Frederick Wheelock. A scholar is included among the top collaborators of Ε. Frederick Wheelock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ε. Frederick Wheelock. Ε. Frederick Wheelock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 20 | |
| 3 | Elimination of L5178Y cells from tumor-dormant DBA/2 mice by specific active immunotherapy. | 6 |
| 4 | Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state. | 8 |
| 5 | 102 | |
| 6 | 49 | |
| 7 | 43 | |
| 8 | A new method for quantitation of cell-mediated immunity in the mouse. | 3 |
| 9 | 21 | |
| 10 | 102 | |
| 11 | 95 | |
| 12 | 71 | |
| 13 | Specific role of each human leukocyte type in viral infections. 3. 17D yellow fever virus replication and interferon production in homogeneous leukocyte cultures treated with phytohemagglutinin. | 40 |
| 14 | 28 | |
| 15 | 18 | |
| 16 | 23 | |
| 17 | Interference in human viral infections: present status and prospects for the future. | 26 |
| 18 | 20 | |
| 19 | 47 | |
| 20 | 37 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.